NeuroSense Therapeutics NRSN
NASDAQ NRSN
$2.44 -0.12 (-4.69%)
At close: Oct 22, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Accumulated Expenses (2020 - 2025)

Updated

NeuroSense Therapeutics' Accumulated Expenses came in at $1.16 million for Q4 2025, up 345.2% from $261,000 a year earlier.

Analysis

NeuroSense Therapeutics (NRSN) Accumulated Expenses (2020 - 2025) Analysis & Trends

Going back to Q4 2020, NeuroSense Therapeutics' Accumulated Expenses data covers 5 quarters.

  • Accumulated Expenses carries a five-year compound annual growth rate of 109.2% (FY2020 to FY2025).
  • Going back by year, Accumulated Expenses was $261,000 in FY2024 (-42.0%), $450,000 in FY2023 and $443,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 NeuroSense Therapeutics 3.97 Mn -469,023.95 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.16 Mn
Dec 31, 2024 261,000.00
Dec 31, 2023 450,000.00
Dec 31, 2021 443,000.00
Dec 31, 2020 29,000.00
API Access

NeuroSense Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NRSN&period=max&api_key=YOUR_API_KEY